Drug
Flonoltinib 100mg
Flonoltinib 100mg is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
2
50%
Ph phase_1
2
50%
Phase Distribution
2
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
2(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Other(1)
Detailed Status
Recruiting2
Completed1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 12 (50.0%)
Phase 22 (50.0%)
Trials by Status
completed125%
unknown125%
recruiting250%
Recent Activity
2 active trials
Showing 4 of 4
recruitingphase_2
Phase IIa Study on Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera
NCT07232290
completedphase_1
Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With Myeloproliferative
NCT05153343
recruitingphase_2
A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis
NCT06457425
unknownphase_1
Study of Flonoltinib Maleate Tablets in the Treatment of Proliferative Bone Marrow Tumors
NCT05115344
Clinical Trials (4)
Showing 4 of 4 trials
NCT07232290Phase 2
Phase IIa Study on Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera
NCT05153343Phase 1
Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With Myeloproliferative
NCT06457425Phase 2
A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis
NCT05115344Phase 1
Study of Flonoltinib Maleate Tablets in the Treatment of Proliferative Bone Marrow Tumors
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4